Lead Central Monitor in London

The Lead Central Monitor (Lead CM) supports the Central Monitoring Head to drive excellence in clinical trial monitoring by establishing and delivering a state-of-the-art Central Monitoring capability at Novartis in Global Clinical Operations (GCO). The Lead CM is responsible for managing a team of CMs, developing central and site monitoring strategies, ensuring that the configuration of the CM platform aligns with strategic needs, and is consistent with identified indications, program, and study risks, in alignment with the IQRMP, to ensure appropriate trial data surveillance in order to deliver quality and integrity of the trials’ clinical data.

The Lead CM will be responsible for a portfolio of programs and related trials within a Development Unit (DU). The role will be responsible for building DU knowledge in the CM team to set adapted strategies for CM. The Lead CM may also have trial’s role:

• During trial start-up, this role will be involved in the protocol development process to support risk identification, risk assessment, and risk oversight (e.g., Key Risks Indicators -KRIs-) in partnership with the Risk Surveillance Lead (RSL).
• During trial execution, the Lead CM will oversee the CMs’ ongoing risk review, checking of the study data, and detection of risks utilizing technology (the CM platform) to monitor data quality, patient safety, and relevant risks.

This role is critical for the oversight of CM’s detection of study-related risk/issue(s) within the scope of study RBM strategy.

Job Responsibilities

• CM Establishment: Support the establishment and implementation of a CM function at Novartis, including processes, tools, and governance frameworks to support RBQM. Contribute to the CM resourcing strategy, including hiring, onboarding, development, and retention of CM Team.
• Team Leadership and Oversight: Manage and mentor a team of CMs, fostering professional development, ensuring alignment with CM processes, and maintaining high performance across the team. Serve as the primary escalation point for CMs, providing guidance on complex risk signals and ensuring timely resolution of critical study-related risks.
• Strategic Input and Coordination: Partner with the CM Head to set, refine and implement the CM strategy, contributing to the continuous improvement of Risk-Based Monitoring (RBM) processes across the organization. Lead efforts to harmonize CM practices across studies, ensuring consistency in risk detection, assessment, and escalation protocols.
• Risk Management and Analytics Leadership: Oversee the analysis and interpretation of CM dashboards and data visualization tools to identify and contextualize risk signals and ensure accurate root cause analysis and mitigation actions. Collaborate with cross-functional study teams, including RSL, Study Leaders, Data Managers, and Clinical Scientific Leaders, to ensure robust risk mitigation plans and issue resolutions are in place and effectively executed.
• Protocol and Study Design Support: Provide strategic input during protocol development and study setup to ensure comprehensive risk identification and alignment with RBQM objectives and processes. Advise on the design and optimization of KRIs and thresholds to enhance the efficacy of CM efforts.
• Data Integrity and Quality through Collaboration: Ensure appropriate trial data surveillance to deliver quality and integrity of the trials’ clinical data. Act as the primary liaison between the CM team and CTTs and to RSL for Critical to Quality (CtQ) risk management, ensuring clear communication and alignment on risk management priorities.
• Performance Tracking and Continuous Improvement: Monitor and report on the effectiveness of CM activities, identifying opportunities for process improvements and driving implementation of enhancements and lessons learned to improve the RBQM (QbD and CM) mitigation strategy.
• Documentation and Compliance: Ensure comprehensive documentation of CM activities, including risk identification, escalation, and resolution, to meet regulatory and internal quality requirements. Oversee audit readiness of CM processes and outputs, supporting inspections and ensuring compliance with regulatory standards.
• Technology and Innovation Leadership: Act as a key stakeholder in the evaluation, adoption, and improvements of the CM tools and technologies, ensuring effective integration into workflows. Drive innovation in the use of analytics, visualization, and data-driven techniques to enhance risk identification and monitoring capabilities.

Job Requirements

• University degree in life science, business or operations; Advanced degree preferred.
• ≥ 7 years of recent pharmaceutical industry experience, with previous experience in clinical research, in a Pharmaceutical Industry or CROs.
• Strong clinical experience with excellent understanding of clinical trial development and risk management processes and the management of clinical trials.
• Specific Central monitoring / monitoring experience (hands-on experience with Key Risk Indicators -KRIs- review, centralized monitoring and quality tolerance limits -QTLs-) are strongly preferred.
• Experience in implementing or working within Risk‑Based Quality Management (RBQM) and adaptive monitoring frameworks.
• ≥ 3 years of recent experience in people management and/or team leadership.
• Strong leadership and people management skills in a global setting and proven ability to develop high performing teams.
• ≥ 5 years comprehensive experience in monitoring (central, site), clinical data analytics, data management activities or equivalent.
• Thorough understanding of the international aspects of drug development process, including expert knowledge of international standards (GCP/ICH), health authorities, and Novartis standards.
• Excellent communication and coordination skills.

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.